BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 3081939)

  • 21. Endogenous thiol levels in heterogeneous murine tumor cells as a function of the physiological state and the response to X-irradiation.
    Dethlefsen LA; Biaglow JE; Peck VM; Ridinger DN
    J Cell Physiol; 1987 Jul; 132(1):149-54. PubMed ID: 3597550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytoprotective effect of gallotannin in oxidatively stressed HaCaT keratinocytes: the role of poly(ADP-ribose) metabolism.
    Bakondi E; Bai P; Erdélyi K; Szabó C; Gergely P; Virág L
    Exp Dermatol; 2004 Mar; 13(3):170-8. PubMed ID: 14987257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FGF2-mediated upregulation of urokinase-type plasminogen activator expression requires a MAP-kinase dependent activation of poly(ADP-ribose) polymerase.
    Caldini R; Barletta E; Del Rosso M; Giovannelli L; Chevanne M
    J Cell Physiol; 2005 Jan; 202(1):125-34. PubMed ID: 15389540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Poly(ADP-ribose) polymerase in base excision repair: always engaged, but not essential for DNA damage processing.
    Allinson SL; Dianova II; Dianov GL
    Acta Biochim Pol; 2003; 50(1):169-79. PubMed ID: 12673357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guanidine group specific ADP-ribosyltransferase in murine cells.
    Soman G; Haregewoin A; Hom RC; Finberg RW
    Biochem Biophys Res Commun; 1991 Apr; 176(1):301-8. PubMed ID: 1902105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of poly(ADP-ribose) polymerase with human autoantibodies.
    Yamanaka H; Penning CA; Willis EH; Wasson DB; Carson DA
    Adv Exp Med Biol; 1989; 253B():259-65. PubMed ID: 2514589
    [No Abstract]   [Full Text] [Related]  

  • 27. Murine mammary tumour cells in vitro. II. Recruitment of quiescent cells.
    Wallen CA; Higashikubo R; Dethlefsen LA
    Cell Tissue Kinet; 1984 Jan; 17(1):79-89. PubMed ID: 6198085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Murine mammary tumour cells in vitro. I. The development of a quiescent state.
    Wallen CA; Higashikubo R; Dethlefsen LA
    Cell Tissue Kinet; 1984 Jan; 17(1):65-77. PubMed ID: 6198084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of nicotinamide adenine dinucleotide and adenosine triphosphate in glucocorticoid-induced cytotoxicity in susceptible lymphoid cells.
    Berger NA; Berger SJ; Sudar DC; Distelhorst CW
    J Clin Invest; 1987 Jun; 79(6):1558-63. PubMed ID: 3108318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ADP-ribosylation, DNA repair, cell differentiation and cancer.
    Shall S
    Princess Takamatsu Symp; 1983; 13():3-25. PubMed ID: 6317641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poly(ADP-ribose) polymerase activity in proliferating and quiescent murine mammary carcinoma cells.
    Sweiger SE; Petzold SJ; Surowy CS; Berger SJ; Dethlefsen LA; Berger NA
    Radiat Res; 1986 Feb; 105(2):219-26. PubMed ID: 3081939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poly(ADP-ribose) polymerase mediates the suicide response to massive DNA damage: studies in normal and DNA-repair defective cells.
    Berger NA; Sims JL; Catino DM; Berger SJ
    Princess Takamatsu Symp; 1983; 13():219-26. PubMed ID: 6317637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneity of X-ray cytotoxicity in proliferating and quiescent murine mammary carcinoma cells.
    Wallen CA; Ridinger DN; Dethlefsen LA
    Cancer Res; 1985 Jul; 45(7):3064-9. PubMed ID: 4005844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poly(ADP-ribose) and the response of cells to ionizing radiation.
    Oleinick NL; Evans HH
    Radiat Res; 1985 Jan; 101(1):29-46. PubMed ID: 3918331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth inhibition and cell killing by N-methyl-N-nitrosourea: metabolic alterations that accompany poly(ADP-ribosyl)ation.
    Mizumoto K; Farber JL
    Arch Biochem Biophys; 1995 Jun; 319(2):512-8. PubMed ID: 7786036
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.